Literature DB >> 22935225

Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosis.

Moritz Binder1, Sophie Christoph, Bettina Sehnert, Markus Uhl, Hans-Hartmut Peter, Reinhard E Voll, Klaus Warnatz, Florian Kollert.   

Abstract

OBJECTIVES: To investigate the role of serum osteopontin concentrations for monitoring idiopathic retroperitoneal fibrosis.
METHODS: In 22 patients with idiopathic retroperitoneal fibrosis serum concentrations of osteopontin were measured by an enzyme-linked immunosorbant assay and related to retrospectively gathered clinical data, contrast enhanced magnetic resonance imaging studies, and laboratory parameters. Patients with secondary causes, an inflammatory abdominal aortic aneurysm, and immunoglobulin G4-associated idiopathic retroperitoneal fibrosis were excluded. Twenty-two healthy volunteers served as controls.
RESULTS: Serum osteopontin concentrations of patients with idiopathic retroperitoneal fibrosis were elevated compared to healthy controls (p=0.017) and correlated with the transverse diameter of the periaortic cuff as determined by imaging studies (ρ=0.549; p=0.008). Patients presenting with a diameter greater than 10mm had higher osteopontin concentrations than patients with smaller diameters (p=0.004). Increased inflammatory activity as determined by the presence of contrast enhancement in imaging studies (p<0.001) and the presence of typical symptoms (p=0.013) were associated with higher osteopontin concentrations.
CONCLUSIONS: Serum osteopontin concentrations were elevated in patients with idiopathic retroperitoneal fibrosis. Increased concentrations correlated with the presence of clinical symptoms and extended disease or activity parameters on magnetic resonance imaging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22935225

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

1.  [Retroperitoneal fibrosis: development of a biomarker profile for diagnosis and therapy monitoring].

Authors:  S Kukuk; A Kretschmer; H Bruck; S Roth; A S Brandt
Journal:  Urologe A       Date:  2015-01       Impact factor: 0.639

2.  Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis.

Authors:  Xia Gao; Guiquan Jia; Anna Guttman; Daryle J DePianto; Katrina B Morshead; Kai-Hui Sun; Nandhini Ramamoorthi; Jason A Vander Heiden; Zora Modrusan; Paul J Wolters; Angelika Jahreis; Joseph R Arron; Dinesh Khanna; Thirumalai R Ramalingam
Journal:  Cell Rep Med       Date:  2020-11-17

3.  Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.

Authors:  Eric S White; Meng Xia; Susan Murray; Rachel Dyal; Candace M Flaherty; Kevin R Flaherty; Bethany B Moore; Ling Cheng; Tracy J Doyle; Julian Villalba; Paul F Dellaripa; Ivan O Rosas; Jonathan D Kurtis; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

4.  The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis.

Authors:  Yanchen Xie; Hai-Feng Li; Liang Sun; Linda L Kusner; Shuhui Wang; Yunxiao Meng; Xu Zhang; Yu Hong; Xiang Gao; Yao Li; Henry J Kaminski
Journal:  Front Neurol       Date:  2017-05-31       Impact factor: 4.003

5.  Elevated osteopontin levels in mild cognitive impairment and Alzheimer's disease.

Authors:  Yuan Sun; Xue Song Yin; Hong Guo; Rong Kun Han; Rui Dong He; Li Jun Chi
Journal:  Mediators Inflamm       Date:  2013-03-14       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.